
Expert Help for Patients at Risk of Kidney Cancer
UNC’s von Hippel-Lindau Comprehensive Clinical Care Center treats familial syndromes with predispositions of kidney cancer.
UNC’s von Hippel-Lindau Comprehensive Clinical Care Center treats familial syndromes with predispositions of kidney cancer.
UNC researchers led the most powerful genomic study of anorexia nervosa conducted to date to identify the common roots anorexia shares with psychiatric and metabolic traits. Cynthia Bulik, PhD, FAED, was the study's lead investigator.
A new NIH-funded consortium in North Carolina will offer Early Check, a free newborn screening done in partnership with the N.C. State Laboratory of Public Health, UNC, Duke University, and Wake Forest Baptist Medical Center.
Babies, Children's Health, Genetics, Pediatric Medicine, Research
By focusing on small molecules called microRNAs in stem cells of the intestine, UNC School of Medicine researchers have proposed a new mechanism by which gut microbes might help keep us healthy or make us sick.
UNC clinical geneticists are part of a national consortium of researchers studying the ins and outs of genome sequencing for newborn health screenings and beyond.
Babies, Children's Health, Genetics, Pediatric Medicine, Research
Susan G. Komen announced UNC Lineberger researcher Charles M. Perou, PhD, as the recipient of this year's Brinker Award for Scientific Distinction in Basic Science for his contributions to the understanding of breast cancer as distinct molecular subtypes that have prognostic value using cutting-edge cancer genomics tools.
A new report in the journal Science describes how the virus can jump species, including to mice – a finding that has major implications for researching the disease and host immune responses to the virus. Jason Whitmire, PhD, and Stanley Lemon, MD, led the research team.
In the journal npj Breast Cancer, researchers reported they identified a particular gene expression pattern in normal-appearing breast tissue around tumors that was linked to lower 10-year survival rates for women with estrogen receptor-positive breast cancer.